Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism TWEAKR antagonists(TNF superfamily receptor 12A antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cachexia | Preclinical | JP | 13 Jun 2022 | |
Solid tumor | Preclinical | JP | 13 Jun 2022 |